Bolt Medical Announces Completion of The RESTORE ATK and RESTORE BTK Pivotal Studies Investigating the Unique Bolt Intravascular Lithotripsy System by Seini Moimoi | Nov 4, 2024 | Portfolio News
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 by Seini Moimoi | Oct 26, 2024 | Portfolio News
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals by Seini Moimoi | Oct 23, 2024 | Portfolio News
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche by Seini Moimoi | Oct 17, 2024 | Portfolio News
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG by Seini Moimoi | Oct 16, 2024 | Portfolio News
OrsoBio Announces Publication of Preclinical Data on Novel Approach for Regulating Metabolic Dysfunction and Reducing Inflammation and Fibrosis by Seini Moimoi | Oct 15, 2024 | Portfolio News
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Oct 15, 2024 | Portfolio News
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement by Seini Moimoi | Oct 1, 2024 | Portfolio News
Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma by Seini Moimoi | Sep 16, 2024 | Portfolio News
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering by Seini Moimoi | Sep 12, 2024 | Portfolio News
